Evidence map›Paper›PMID 40680117›Full record

ArticleScience advances2025

Image-based inference of tumor cell trajectories enables large-scale cancer progression analysis.

Yang Liu, Ling Cai, Ruichen Rong, Shidan Wang, Liwei Jia, Peiran Quan, Qin Zhou, Guanghua Xiao, Yang Xie

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yang LiuQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0001-6979-2518
Ling CaiQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0002-9057-2998
Ruichen RongQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Shidan WangQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0002-0001-3261
Liwei JiaDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0002-2118-6428
Peiran QuanQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Qin ZhouQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0002-7269-1731
Guanghua XiaoQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0001-9387-9883
Yang XieQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0001-9456-1762

Funding

Construction of A Lung Cancer Preclinical Model Cross-comparison PlatformR01CA285336 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Ling Cai · 2024 to 2026
$3.1M
Novel computational approaches to predict drug response and combination effectsR35GM136375 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI XIE, YANG · 2020 to 2024
$2.0M
Developing novel algorithms for spatial molecular profiling technologiesR01GM141519 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI XIAO, GUANGHUA · 2021 to 2024
$1.4M
NCI NIH HHS R01 CA285336NIGMS NIH HHS R01 GM141519NIGMS NIH HHS R35 GM136375
6 · The paper itself

Abstract

Current approaches to estimating cell trajectories, tumor progression dynamics, and cell population diversity of tumor microenvironment often depend on single-cell RNA sequencing, which is costly and resource intensive. To address this limitation, we developed an artificial intelligence (AI) model that leverages cell morphology features and histological spatial organization to classify tumor cell differentiation status, infer cell dynamic trajectories, and quantify tumor progression from hematoxylin and eosin (H&E)-stained whole-slide images. In three independent lung adenocarcinoma cohorts, our AI-based model accurately predicted cell differential status and provided quantifiable measures of tumor progression that were prognostic of patient survival. Spatial transcriptomic integrative analyses revealed cell components and gene signatures enriched in different cell differentiation statuses. Bulk transcriptomic analyses revealed that fast-progressing tumors exhibit up-regulated cell cycle pathways, while slow-progressing tumors retain characteristics of normal lung epithelium. This cost-effective method enables large-scale analysis of tumor progression dynamics using routinely collected pathology slides and provides insights into intratumor heterogeneity.

Indexed as

Adenocarcinoma of LungImage Processing, Computer-AssistedLung NeoplasmsNeoplasmsArtificial IntelligenceDisease ProgressionGene Expression ProfilingHumansPrognosisTranscriptomeTumor Microenvironment

Identifiers

PMID40680117
PMCPMC12273761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.